These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 11756171)

  • 21. Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation.
    Kamae T; Shiraga M; Kashiwagi H; Kato H; Tadokoro S; Kurata Y; Tomiyama Y; Kanakura Y
    J Thromb Haemost; 2006 Jun; 4(6):1379-87. PubMed ID: 16706985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
    Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
    Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.
    Kauffenstein G; Bergmeier W; Eckly A; Ohlmann P; Léon C; Cazenave JP; Nieswandt B; Gachet C
    FEBS Lett; 2001 Sep; 505(2):281-90. PubMed ID: 11566191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.
    Liu J; Pestina TI; Berndt MC; Steward SA; Jackson CW; Gartner TK
    J Thromb Haemost; 2004 Dec; 2(12):2213-22. PubMed ID: 15613029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation.
    Shankar H; Garcia A; Prabhakar J; Kim S; Kunapuli SP
    J Thromb Haemost; 2006 Mar; 4(3):638-47. PubMed ID: 16460446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
    Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
    Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM; Buckland RJ; Holgate CE; Storey RF
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
    Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P2 receptors and platelet activation.
    Kunapuli SP
    ScientificWorldJournal; 2002 Feb; 2():424-33. PubMed ID: 12806027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets.
    Nieswandt B; Schulte V; Zywietz A; Gratacap MP; Offermanns S
    J Biol Chem; 2002 Oct; 277(42):39493-8. PubMed ID: 12183468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
    Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
    Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation.
    Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC
    Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G(12/13) signaling pathways substitute for integrin αIIbβ3-signaling for thromboxane generation in platelets.
    Bhavaraju K; Lakhani PR; Dorsam RT; Jin J; Hitchcock IS; Sanjay A; Kunapuli SP
    PLoS One; 2011 Feb; 6(2):e16586. PubMed ID: 21347357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
    Shattil SJ; Haimovich B; Cunningham M; Lipfert L; Parsons JT; Ginsberg MH; Brugge JS
    J Biol Chem; 1994 May; 269(20):14738-45. PubMed ID: 7514181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross talk between serine/threonine and tyrosine kinases regulates ADP-induced thromboxane generation in platelets.
    Bhavanasi D; Badolia R; Manne BK; Janapati S; Dangelmaier CT; Mazharian A; Jin J; Kim S; Zhang X; Chen X; Senis YA; Kunapuli SP
    Thromb Haemost; 2015 Aug; 114(3):558-68. PubMed ID: 25947062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets.
    Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ
    Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range.
    Horner S; Menke K; Hildebrandt C; Kassack MU; Nickel P; Ullmann H; Mahaut-Smith MP; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):1-13. PubMed ID: 16158305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.